Comgest Global Investors S.A.S. Sells 10,290 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Comgest Global Investors S.A.S. lessened its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 2.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 383,830 shares of the company’s stock after selling 10,290 shares during the quarter. Comgest Global Investors S.A.S.’s holdings in Stevanato Group were worth $7,677,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. nVerses Capital LLC purchased a new position in Stevanato Group during the 3rd quarter worth $84,000. Hilltop National Bank boosted its holdings in Stevanato Group by 34.3% during the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock worth $81,000 after acquiring an additional 1,122 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new position in Stevanato Group during the 1st quarter worth $241,000. Harbor Capital Advisors Inc. boosted its holdings in Stevanato Group by 109.1% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock worth $163,000 after acquiring an additional 4,626 shares during the last quarter. Finally, Raymond James Trust N.A. boosted its holdings in Stevanato Group by 18.7% during the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after acquiring an additional 1,613 shares during the last quarter.

Analyst Upgrades and Downgrades

Separately, Citigroup cut their price objective on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th.

Stevanato Group Stock Performance

Shares of NYSE:STVN traded down €1.50 ($1.58) during midday trading on Friday, reaching €19.00 ($20.00). The company had a trading volume of 507,600 shares, compared to its average volume of 512,588. The company’s 50 day moving average price is €19.56 and its 200 day moving average price is €20.05. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The stock has a market cap of $5.62 billion, a P/E ratio of 40.43, a P/E/G ratio of 9.25 and a beta of 0.58. Stevanato Group S.p.A. has a 52-week low of €16.56 ($17.43) and a 52-week high of €34.73 ($36.56).

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Stevanato Group’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period last year, the firm posted $0.16 earnings per share. As a group, sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.